Treatment of Helicobacter pylori

被引:20
作者
Hoffman, JS [1 ]
Cave, DR [1 ]
机构
[1] St Elizabeths Med Ctr, Div Gastroenterol, Brighton, MA 02135 USA
关键词
D O I
10.1097/00001574-200101000-00006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Helicobacter pylori causes several gastroduodenal diseases. Various antibiotic regimens are available that eradicate H. pylori in 80 to 90% of patients, but no regimen cures all patients. Dual therapy is now obsolete. Triple therapy with two antibiotics and either a proton pump inhibitor or bismuth is the regimens of choice. Metronidazole and clarithromycin are the two key antibiotics. Antibiotic resistance against these two drugs is becoming more problematic and should be taken into consideration when choosing a regimen, Antibiotic resistance is usually induced after failure. Quadruple therapy has been used as a salvage regimen in failed cases but it is also the most complicated regimen. Several new agents are being studied including a single capsule that contains bismuth, metronidazole, and tetracycline. (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:30 / 34
页数:5
相关论文
共 34 条
[1]  
Bayerdörffer E, 1999, ALIMENT PHARM THERAP, V13, P1639
[2]  
Calvet X, 2000, ALIMENT PHARM THER, V14, P603
[3]  
Chan FKL, 2000, ALIMENT PHARM THER, V14, P91
[4]  
Dani R, 1999, ALIMENT PHARM THERAP, V13, P1647
[5]  
de Boer WA, 2000, AM J GASTROENTEROL, V95, P641, DOI 10.1111/j.1572-0241.2000.01971.x
[6]  
de Boer WA, 2000, ALIMENT PHARM THERAP, V14, P85
[7]   Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy -: A meta-analytical approach [J].
Dore, MP ;
Leandro, G ;
Realdi, G ;
Sepulveda, AR ;
Graham, DY .
DIGESTIVE DISEASES AND SCIENCES, 2000, 45 (01) :68-76
[8]  
Fairman KA, 2000, ANN PHARMACOTHER, V34, P721
[9]   Effectiveness of Helicobacter pylori therapies in a clinical practice setting [J].
Fennerty, MB ;
Lieberman, DA ;
Vakil, N ;
Margaret, N ;
Faigel, DO ;
Helfand, M .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (14) :1562-1566
[10]  
Fock KM, 2000, ALIMENT PHARM THER, V14, P225, DOI 10.1046/j.1365-2036.2000.00691.x